249 related articles for article (PubMed ID: 22331495)
1. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs.
Tolosa L; Pinto S; Donato MT; Lahoz A; Castell JV; O'Connor JE; Gómez-Lechón MJ
Toxicol Sci; 2012 May; 127(1):187-98. PubMed ID: 22331495
[TBL] [Abstract][Full Text] [Related]
2. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
3. HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved.
Tolosa L; Gómez-Lechón MJ; Pérez-Cataldo G; Castell JV; Donato MT
Arch Toxicol; 2013 Jun; 87(6):1115-27. PubMed ID: 23397584
[TBL] [Abstract][Full Text] [Related]
4. Application of a high-content multiparameter cytotoxicity assay to prioritize compounds based on toxicity potential in humans.
Abraham VC; Towne DL; Waring JF; Warrior U; Burns DJ
J Biomol Screen; 2008 Jul; 13(6):527-37. PubMed ID: 18566484
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
Ware BR; Berger DR; Khetani SR
Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
[TBL] [Abstract][Full Text] [Related]
6. High-content screening technology for studying drug-induced hepatotoxicity in cell models.
Tolosa L; Gómez-Lechón MJ; Donato MT
Arch Toxicol; 2015 Jul; 89(7):1007-22. PubMed ID: 25787152
[TBL] [Abstract][Full Text] [Related]
7. High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins.
Tolosa L; Carmona A; Castell JV; Gómez-Lechón MJ; Donato MT
Arch Toxicol; 2015 Oct; 89(10):1847-60. PubMed ID: 25160661
[TBL] [Abstract][Full Text] [Related]
8. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
[TBL] [Abstract][Full Text] [Related]
9. A high content screening assay to predict human drug-induced liver injury during drug discovery.
Persson M; Løye AF; Mow T; Hornberg JJ
J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
[TBL] [Abstract][Full Text] [Related]
10. High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.
Grimm FA; Iwata Y; Sirenko O; Bittner M; Rusyn I
Assay Drug Dev Technol; 2015 Nov; 13(9):529-46. PubMed ID: 26539751
[TBL] [Abstract][Full Text] [Related]
11. Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies.
Donato MT; Gómez-Lechón MJ; Tolosa L
Expert Opin Drug Discov; 2017 Feb; 12(2):201-211. PubMed ID: 27936962
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric High-Content Assays to Measure Cell Health and Oxidative Damage as a Model for Drug-Induced Liver Injury.
Pohan G; Espinosa JA; Chen S; Ang KK; Arkin MR; Markossian S
Curr Protoc Chem Biol; 2020 Dec; 12(4):e90. PubMed ID: 33315311
[TBL] [Abstract][Full Text] [Related]
13. Implication of hepatic transporters (MDR1 and MRP2) in inflammation-associated idiosyncratic drug-induced hepatotoxicity investigated by microvolume cytometry.
Saab L; Peluso J; Muller CD; Ubeaud-Sequier G
Cytometry A; 2013 Apr; 83(4):403-8. PubMed ID: 23401306
[TBL] [Abstract][Full Text] [Related]
14. Long-term and mechanistic evaluation of drug-induced liver injury in Upcyte human hepatocytes.
Tolosa L; Jiménez N; Pelechá M; Castell JV; Gómez-Lechón MJ; Donato MT
Arch Toxicol; 2019 Feb; 93(2):519-532. PubMed ID: 30426164
[TBL] [Abstract][Full Text] [Related]
15. Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury.
Tolosa L; Jiménez N; Pérez G; Castell JV; Gómez-Lechón MJ; Donato MT
Arch Toxicol; 2018 Jan; 92(1):383-399. PubMed ID: 28762043
[TBL] [Abstract][Full Text] [Related]
16. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes.
Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y
Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329
[TBL] [Abstract][Full Text] [Related]
17. Rat liver clone-9 cells in culture as a model for screening hepatotoxic potential of food-related products: hepatotoxicity of deoxynivalenol.
Sahu SC; Garthoff LH; Robl MG; Chirtel SJ; Ruggles DI; Flynn TJ; Sobotka TJ
J Appl Toxicol; 2008 Aug; 28(6):765-72. PubMed ID: 18300328
[TBL] [Abstract][Full Text] [Related]
18. Real-time concurrent monitoring of apoptosis, cytosolic calcium, and mitochondria permeability transition for hypermulticolor high-content screening of drug-induced mitochondrial dysfunction-mediated hepatotoxicity.
Kim JA; Han E; Eun CJ; Tak YK; Song JM
Toxicol Lett; 2012 Oct; 214(2):175-81. PubMed ID: 22981620
[TBL] [Abstract][Full Text] [Related]
19. A micropatterned hepatocyte coculture model for assessment of liver toxicity using high-content imaging analysis.
Trask OJ; Moore A; LeCluyse EL
Assay Drug Dev Technol; 2014; 12(1):16-27. PubMed ID: 24444127
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of toxicity associated with six tyrosine kinase inhibitors in human hepatocyte cell lines.
Mingard C; Paech F; Bouitbir J; Krähenbühl S
J Appl Toxicol; 2018 Mar; 38(3):418-431. PubMed ID: 29072336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
